Paliperidone Palmitate Stada

Paliperidone, the active ingredient in Paliperidone Palmitate Stada, is a atypical antipsychotic presented as a long‑acting injectable suspension for intramuscular use. It treats schizophrenia in adults and adolescents. GNH USA supplies Paliperidone Palmitate Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Paliperidone Palmitate Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Paliperidone Palmitate is a long‑acting antipsychotic indicated for the treatment of schizophrenia.

- Schizophrenia: Reduces risk of relapse and stabilises psychotic symptoms. - Schizoaffective disorder: Controls mood‑related psychotic episodes. - Maintenance therapy: Provides consistent plasma levels to support long‑term disease management.

Paliperidone may elicit a range of adverse reactions, most of which are dose‑dependent and reversible.

Common Side Effects: - Ak Ak  -   t   t  t  t -  \n-  t -  g  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  - -  -  t -  t -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  - -  -  - -  -  - - - -  -  - -  -  - -  -  -

Serious or Rare  i  t

t

t

t

t

t i

t ",

Paliperidone  g  ewline

  ewline 

t \